Stocks In News - USFDA

1. Laurus Labs has received USFDA approval for Metformin Hydrochloride tablets.
2. The company has received an approval from USFDA (United States Food and Drug Administration) for Metformin Hydrochloride Tablets USP 500mg, 850mg and 1000mg which are used for treatment of diabetes.
3. Metformin Hydrochloride Tablets are therapeutically equivalent to Glucophage Tablets 500mg, 850mg, and 1000 mg of Bristol-Myers Squibb company.
4. The Product and API will be commercialized from company's Unit 2 located at APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.